J S Cooper. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Antineoplastic Agents/therapeutic useCisplatin/therapeutic useCombined Modality TherapyHumansNasopharyngeal Neoplasms/drug therapyNasopharyngeal Neoplasms/pathologyNasopharyngeal Neoplasms/radiotherapyRadiation-Sensitizing Agents/therapeutic useSurvival Rate
Substances: See more » Antineoplastic AgentsRadiation-Sensitizing AgentsCisplatin
Year: 2000 PMID: 11121623 DOI: 10.1016/s0360-3016(00)00778-1
Source DB: PubMed Journal: Int J Radiat Oncol Biol Phys ISSN: 0360-3016 Impact factor: 7.038